• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于肺癌分子谱分析的自动化肿瘤分析

Automated tumor analysis for molecular profiling in lung cancer.

作者信息

Hamilton Peter W, Wang Yinhai, Boyd Clinton, James Jacqueline A, Loughrey Maurice B, Hougton Joseph P, Boyle David P, Kelly Paul, Maxwell Perry, McCleary David, Diamond James, McArt Darragh G, Tunstall Jonathon, Bankhead Peter, Salto-Tellez Manuel

机构信息

Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.

PathXL Ltd, Northern Ireland Science Park, Belfast, UK.

出版信息

Oncotarget. 2015 Sep 29;6(29):27938-52. doi: 10.18632/oncotarget.4391.

DOI:10.18632/oncotarget.4391
PMID:26317646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4695036/
Abstract

The discovery and clinical application of molecular biomarkers in solid tumors, increasingly relies on nucleic acid extraction from FFPE tissue sections and subsequent molecular profiling. This in turn requires the pathological review of haematoxylin & eosin (H&E) stained slides, to ensure sample quality, tumor DNA sufficiency by visually estimating the percentage tumor nuclei and tumor annotation for manual macrodissection. In this study on NSCLC, we demonstrate considerable variation in tumor nuclei percentage between pathologists, potentially undermining the precision of NSCLC molecular evaluation and emphasising the need for quantitative tumor evaluation. We subsequently describe the development and validation of a system called TissueMark for automated tumor annotation and percentage tumor nuclei measurement in NSCLC using computerized image analysis. Evaluation of 245 NSCLC slides showed precise automated tumor annotation of cases using Tissuemark, strong concordance with manually drawn boundaries and identical EGFR mutational status, following manual macrodissection from the image analysis generated tumor boundaries. Automated analysis of cell counts for % tumor measurements by Tissuemark showed reduced variability and significant correlation (p < 0.001) with benchmark tumor cell counts. This study demonstrates a robust image analysis technology that can facilitate the automated quantitative analysis of tissue samples for molecular profiling in discovery and diagnostics.

摘要

实体瘤中分子生物标志物的发现及临床应用,越来越依赖于从福尔马林固定石蜡包埋(FFPE)组织切片中提取核酸并进行后续的分子分析。这反过来又需要对苏木精和伊红(H&E)染色的玻片进行病理检查,以确保样本质量、通过目测估计肿瘤细胞核百分比来评估肿瘤DNA的充足性,以及为手动宏观解剖进行肿瘤标注。在这项关于非小细胞肺癌(NSCLC)的研究中,我们证明了病理学家之间肿瘤细胞核百分比存在相当大的差异,这可能会削弱NSCLC分子评估的准确性,并强调了进行定量肿瘤评估的必要性。我们随后描述了一种名为TissueMark的系统的开发和验证,该系统使用计算机图像分析对NSCLC进行自动肿瘤标注和肿瘤细胞核百分比测量。对245张NSCLC玻片的评估显示,使用TissueMark对病例进行了精确的自动肿瘤标注,与手动绘制的边界高度一致,并且在从图像分析生成的肿瘤边界进行手动宏观解剖后,EGFR突变状态相同。TissueMark对肿瘤细胞百分比测量的细胞计数自动分析显示变异性降低,并且与基准肿瘤细胞计数具有显著相关性(p < 0.001)。这项研究展示了一种强大的图像分析技术,该技术可以促进对组织样本进行自动定量分析,以用于发现和诊断中的分子分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/e2485731e9c2/oncotarget-06-27938-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/1d5158ee5509/oncotarget-06-27938-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/0dc5972b58a7/oncotarget-06-27938-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/20d7f83cbbba/oncotarget-06-27938-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/88ae20957a6e/oncotarget-06-27938-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/1becd38a8395/oncotarget-06-27938-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/a6f841aab848/oncotarget-06-27938-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/13e52912fc79/oncotarget-06-27938-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/bf88a56b737f/oncotarget-06-27938-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/e829264afa16/oncotarget-06-27938-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/459b589c2a86/oncotarget-06-27938-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/e2485731e9c2/oncotarget-06-27938-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/1d5158ee5509/oncotarget-06-27938-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/0dc5972b58a7/oncotarget-06-27938-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/20d7f83cbbba/oncotarget-06-27938-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/88ae20957a6e/oncotarget-06-27938-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/1becd38a8395/oncotarget-06-27938-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/a6f841aab848/oncotarget-06-27938-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/13e52912fc79/oncotarget-06-27938-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/bf88a56b737f/oncotarget-06-27938-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/e829264afa16/oncotarget-06-27938-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/459b589c2a86/oncotarget-06-27938-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/4695036/e2485731e9c2/oncotarget-06-27938-g011.jpg

相似文献

1
Automated tumor analysis for molecular profiling in lung cancer.用于肺癌分子谱分析的自动化肿瘤分析
Oncotarget. 2015 Sep 29;6(29):27938-52. doi: 10.18632/oncotarget.4391.
2
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer.非小细胞肺癌中 PD-L1 表达异质性的定量评估。
JAMA Oncol. 2016 Jan;2(1):46-54. doi: 10.1001/jamaoncol.2015.3638.
3
Automated recognition of cell phenotypes in histology images based on membrane- and nuclei-targeting biomarkers.基于膜靶向和核靶向生物标志物的组织学图像中细胞表型的自动识别。
BMC Med Imaging. 2007 Sep 6;7:7. doi: 10.1186/1471-2342-7-7.
4
Digital image analysis of pan-cytokeratin stained tumor slides for evaluation of tumor budding in pT1/pT2 colorectal cancer: Results of a feasibility study.用于评估pT1/pT2期结直肠癌肿瘤芽生的全细胞角蛋白染色肿瘤切片的数字图像分析:一项可行性研究的结果
Pathol Res Pract. 2018 Sep;214(9):1273-1281. doi: 10.1016/j.prp.2018.07.002. Epub 2018 Jul 10.
5
Inter-observer reproducibility of semi-automatic tumor diameter measurement and volumetric analysis in patients with lung cancer.肺癌患者半自动肿瘤直径测量和容积分析的观察者间可重复性。
Lung Cancer. 2013 Oct;82(1):76-82. doi: 10.1016/j.lungcan.2013.07.006. Epub 2013 Aug 8.
6
Validation of mitosis counting by automated phosphohistone H3 (PHH3) digital image analysis in a breast carcinoma tissue microarray.通过自动磷酸化组蛋白H3(PHH3)数字图像分析对乳腺癌组织微阵列中的有丝分裂计数进行验证。
Pathology. 2015 Jun;47(4):329-34. doi: 10.1097/PAT.0000000000000248.
7
Quantification of diverse subcellular immunohistochemical markers with clinicobiological relevancies: validation of a new computer-assisted image analysis procedure.具有临床生物学相关性的多种亚细胞免疫组化标志物的定量分析:一种新型计算机辅助图像分析程序的验证
J Anat. 2008 Jun;212(6):868-78. doi: 10.1111/j.1469-7580.2008.00910.x.
8
Three-dimensional lung tumor segmentation from x-ray computed tomography using sparse field active models.基于稀疏域主动模型的 X 射线计算机断层扫描三维肺肿瘤分割。
Med Phys. 2012 Feb;39(2):851-65. doi: 10.1118/1.3676687.
9
An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma.肾上腺皮质癌的国际Ki67重复性研究。
Am J Surg Pathol. 2016 Apr;40(4):569-76. doi: 10.1097/PAS.0000000000000574.
10
Concordance in the estimation of tumor percentage in non-small cell lung cancer using digital pathology.数字病理学在非小细胞肺癌肿瘤百分比估计中的一致性。
Sci Rep. 2024 Oct 15;14(1):24163. doi: 10.1038/s41598-024-75175-w.

引用本文的文献

1
Utility of a Novel High-Sensitivity Multiplex Companion Diagnostic Test Using Formalin-Fixed Paraffin-Embedded Cell Block Materials of Non-small Cell Lung Cancer.使用非小细胞肺癌福尔马林固定石蜡包埋细胞块材料的新型高灵敏度多重伴随诊断测试的效用
Cancer Med. 2025 Jul;14(13):e71028. doi: 10.1002/cam4.71028.
2
MLCDL: A Critical Practice and Implementation of Multi-tissue Classification and Diagnosis Using Deep Learning Algorithm.MLCDL:一种使用深度学习算法进行多组织分类与诊断的关键实践与实现
Methods Mol Biol. 2025;2952:297-313. doi: 10.1007/978-1-0716-4690-8_18.
3
Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis.

本文引用的文献

1
PICan: An integromics framework for dynamic cancer biomarker discovery.PICan:用于动态癌症生物标志物发现的整合组学框架。
Mol Oncol. 2015 Jun;9(6):1234-40. doi: 10.1016/j.molonc.2015.02.002. Epub 2015 Mar 4.
2
Digital pathology and image analysis in tissue biomarker research.组织生物标志物研究中的数字病理学与图像分析
Methods. 2014 Nov;70(1):59-73. doi: 10.1016/j.ymeth.2014.06.015. Epub 2014 Jul 15.
3
Tumor cellularity as a quality assurance measure for accurate clinical detection of BRAF mutations in melanoma.肿瘤细胞密度作为黑色素瘤中BRAF突变准确临床检测的质量保证指标。
利用深度学习评估结直肠癌肿瘤纯度及其对分子分析的影响
J Pathol. 2025 Feb;265(2):184-197. doi: 10.1002/path.6376. Epub 2024 Dec 22.
4
The crucial role of bioimage analysts in scientific research and publication.生物影像分析师在科学研究和出版中的关键作用。
J Cell Sci. 2024 Oct 15;137(20). doi: 10.1242/jcs.262322. Epub 2024 Oct 30.
5
Deep learning analysis of histopathological images predicts immunotherapy prognosis and reveals tumour microenvironment features in non-small cell lung cancer.深度学习分析组织病理学图像预测非小细胞肺癌的免疫治疗预后并揭示肿瘤微环境特征。
Br J Cancer. 2024 Dec;131(11):1833-1845. doi: 10.1038/s41416-024-02856-8. Epub 2024 Oct 25.
6
Deep learning application in prediction of cancer molecular alterations based on pathological images: a bibliographic analysis via CiteSpace.深度学习在基于病理图像的癌症分子改变预测中的应用:基于 CiteSpace 的文献分析。
J Cancer Res Clin Oncol. 2024 Oct 18;150(10):467. doi: 10.1007/s00432-024-05992-z.
7
Concordance in the estimation of tumor percentage in non-small cell lung cancer using digital pathology.数字病理学在非小细胞肺癌肿瘤百分比估计中的一致性。
Sci Rep. 2024 Oct 15;14(1):24163. doi: 10.1038/s41598-024-75175-w.
8
MetFinder: A Tool for Automated Quantitation of Metastatic Burden in Histological Sections From Preclinical Models.MetFinder:一种用于自动定量临床前模型组织学切片中转移负荷的工具。
Pigment Cell Melanoma Res. 2025 Jan;38(1):e13195. doi: 10.1111/pcmr.13195. Epub 2024 Sep 10.
9
Low densities of immune cells indicate unfavourable overall survival in patients suffering from squamous cell carcinoma of the lung.免疫细胞密度低表明患有肺鳞状细胞癌的患者总体生存状况不佳。
Sci Rep. 2024 Jun 20;14(1):14250. doi: 10.1038/s41598-024-64956-y.
10
Digital counting of tissue cells for molecular analysis: the QuANTUM pipeline.用于分子分析的组织细胞数字计数:量子工作流程。
Virchows Arch. 2025 Feb;486(2):277-286. doi: 10.1007/s00428-024-03794-9. Epub 2024 Mar 26.
Mol Diagn Ther. 2014 Aug;18(4):409-18. doi: 10.1007/s40291-014-0091-6.
4
A prospective, multi-institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cells.一项前瞻性、多机构的诊断试验,旨在确定病理学家在估计恶性细胞百分比方面的准确性。
Arch Pathol Lab Med. 2013 Nov;137(11):1545-9. doi: 10.5858/arpa.2012-0561-CP.
5
The estimation of tumor cell percentage for molecular testing by pathologists is not accurate.病理学家对分子检测进行肿瘤细胞百分比估计并不准确。
Mod Pathol. 2014 Feb;27(2):168-74. doi: 10.1038/modpathol.2013.134. Epub 2013 Jul 26.
6
A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistry.在肺癌中比较 EGFR 基因突变检测方法:直接测序、实时 PCR 和免疫组织化学。
PLoS One. 2012;7(8):e43842. doi: 10.1371/journal.pone.0043842. Epub 2012 Aug 27.
7
Virtual microscopy and digital pathology in training and education.虚拟显微镜和数字病理学在培训和教育中的应用。
APMIS. 2012 Apr;120(4):305-15. doi: 10.1111/j.1600-0463.2011.02869.x.
8
Preparing for precision medicine.为精准医学做准备。
N Engl J Med. 2012 Feb 9;366(6):489-91. doi: 10.1056/NEJMp1114866. Epub 2012 Jan 18.
9
Targeted therapies for lung cancer: clinical experience and novel agents.肺癌的靶向治疗:临床经验与新型药物。
Cancer J. 2011 Nov-Dec;17(6):512-27. doi: 10.1097/PPO.0b013e31823e701a.
10
A new frontier in personalized cancer therapy: mapping molecular changes.个性化癌症治疗的新前沿:绘制分子变化图谱。
Future Oncol. 2011 Jul;7(7):873-94. doi: 10.2217/fon.11.63.